The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
about
Post-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodesAltered radiation fractionation schedules for clinically localised and locally advanced prostate cancerPartial breast irradiation for early breast cancerPost-mastectomy radiotherapy for breast cancer patients with 1 to 3 positive lymph nodesFraction size in radiation treatment for breast conservation in early breast cancerFraction size in radiation therapy for breast conservation in early breast cancerPartial breast irradiation for early breast cancerHypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgeryEmerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast CancerHypofractionated Radiotherapy as Adjuvant Treatment in Early Breast Cancer. A Review and Meta-Analysis of Randomized Controlled TrialsEarly-Stage Breast Cancer in the Elderly: Confronting an Old Clinical ProblemThe evolution of the locoregional therapy of breast cancerReview of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task forceOptimal management of breast cancer in the elderly patient: current perspectivesAdjuvant treatment for older women with invasive breast cancerCurrent role of modern radiotherapy techniques in the management of breast cancerAGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Use of low-value radiotherapy practices in Canada: an analysis of provincial cancer registry data.Whole breast irradiation vs. APBI using multicatheter brachytherapy in early breast cancer - simulation of treatment costs based on phase 3 trial dataFeasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer.Evidence from a breast cancer hypofractionated schedule: late skin toxicity assessed by ultrasound.Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factorsAcute radiation dermatitis in breast cancer patients: challenges and solutionsHitting the right spot.Optimal approach in early breast cancer: Radiation therapyAccelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.Breast cancer: Actual methods of treatment and future trends.Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet instituteThe potential role of three-dimensional surface imaging as a tool to evaluate aesthetic outcome after Breast Conserving Therapy (BCT)Biological dosimetry for breast cancer radiotherapy: a comparison of external beam and intraoperative radiotherapy.Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacyHypofractionated radiotherapy and adjuvant chemotherapy do not increase radiation-induced dermatitis in breast cancer patientsBoost IORT in Breast Cancer: Body of Evidence.Radiotherapy in the management of early breast cancer.Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapyMeasurement of mean cardiac dose for various breast irradiation techniques and corresponding risk of major cardiovascular event.Hypofractionated radiotherapy in the treatment of early breast cancer.Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity.A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effectsTreatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer.
P2860
Q24186275-B57F2EA1-62EB-49BE-8A87-E4E9408E022EQ24186971-4AC49BFA-1100-4A2B-943C-E37A34E198FCQ24193898-C8CAF58F-49E4-4745-B1F9-9AF0ED2F61D0Q24203952-ACFAF8DF-B029-492E-A9DD-7336A9C8245DQ24236396-A2586BE2-7869-4A80-88DD-B10A4D435BECQ26471067-B31C033D-BCEF-4F28-A723-B0F0244070E5Q26471072-0F4906A4-8067-4850-A4BF-887B39C284BDQ26745834-77096B52-753D-443F-A3E9-11F7B83647E7Q26774616-90882497-789D-4E7B-9E5E-6F63411C89C8Q26776288-74DAC3A3-9F9A-4971-AE54-A871AF9CA7E1Q26782584-9929EF90-0B12-48F5-80FD-83DC594DD4C9Q26992321-22BA4B6E-DFAA-4819-B7DB-EB3D44A37489Q27009163-5CE5B682-0D2A-4BDB-918F-D355CA724639Q27690879-5B3E3DE9-5A13-464B-98BE-24298D2AD5B9Q28066744-B53DD8C8-BB1D-499C-B93C-F7618B9BA91DQ28972351-25E0364D-8E5D-4F3D-8E33-F645D1E6C87BQ30318240-53B86724-2782-41F5-9810-4301889045DAQ31140437-7C00D9EB-6D1B-45F6-A14A-EE567BF36A4DQ31156274-240D21B9-4319-41A4-B6FF-45EB43D9C576Q33383943-C968E73D-737F-4D5B-8265-0FFAF1247317Q33643750-1D1783AC-4FE4-4368-975A-DFD241401B6BQ33646182-ACF25AC4-F9EA-46A8-8A57-C43579CDB8E9Q33662782-815E2168-7065-4E10-8859-85E1D4248AEBQ33688952-6C488830-DF88-47E3-ADCD-D9AF69B079B0Q33699050-2D76B327-0827-467A-9B32-13273E1D37BAQ33723980-AA351B76-366D-41F9-A45F-2001BCF62011Q33751802-8856E02F-D722-4D5D-A30C-FA416C7CADC1Q33804575-231EB060-F729-4898-A29C-E705429EE6CEQ33843735-1C545179-D730-4C70-9603-EFDB8225EBAFQ33887892-F4D8B3A5-7FBA-4817-A5D4-5889B1C1AF7FQ33957583-48D454C4-FDF7-49F5-8FE6-C9F816A7FB24Q34171934-2F0C428E-634F-4CD8-B5E0-FD4E3D2352F1Q34203340-3D779B28-4650-48BA-B613-7C7359A2E03BQ34247346-EF1DC934-B4FB-44AC-A677-FC458D060858Q34316748-83C61EFD-B4EE-4137-B6A5-08FCDCE7926DQ34384919-B5B1CCCE-3FEC-4FEE-9D10-0F2E3F088787Q34391739-4D3AE1AE-8094-4252-B624-CC9F6C9A2742Q34397964-CDF14F3F-4646-4223-82CC-0F0D61F6FE2AQ34408374-8B761D11-2FAE-4EC0-BED8-B8DC05CDA97FQ34417188-D2839ADA-7D85-4BC7-921E-AECE9F45E51C
P2860
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The UK Standardisation of Brea ...... st cancer: a randomised trial.
@ast
The UK Standardisation of Brea ...... st cancer: a randomised trial.
@en
type
label
The UK Standardisation of Brea ...... st cancer: a randomised trial.
@ast
The UK Standardisation of Brea ...... st cancer: a randomised trial.
@en
prefLabel
The UK Standardisation of Brea ...... st cancer: a randomised trial.
@ast
The UK Standardisation of Brea ...... st cancer: a randomised trial.
@en
P2093
P2860
P50
P1433
P1476
The UK Standardisation of Brea ...... ast cancer: a randomised trial
@en
P2093
E G A Aird
J M Barrett
P2860
P304
P356
10.1016/S0140-6736(08)60348-7
P407
P577
2008-03-19T00:00:00Z